Why Brexit has doomed your pension

Brexit has sent shockwaves through the financial world and could have doomed some workers’ pensions.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Brexit will have a substantial impact on the lives of people across the UK, and one area where its effects are already being felt is in the pensions industry. Since 24 June, financial markets have been in risk-off mode. Investors have dumped equities and risky assets in favour of assets that are perceived to have less risk such as government bonds and gold.

This sudden rush towards government securities has pushed down yields, (as bond prices rise, yields fall) which is great news for borrowers but bad news for bond investors who are now getting a lower return on their investment.

More for less

The single largest buyers of government bonds (excluding central banks via QE) are pension funds. The high quality and long-term nature of government bonds makes them the perfect assets for pension funds that have to match today’s inflows from contributors to future liabilities or pension outflows.

With yields falling this task of matching inflows with future outflows is becoming harder and harder. Most pension funds target a return of 5% to 10% a year on their assets. With most government bonds now yielding less than 2%, it’s easy to see the scale of the problem facing the industry.

Defined benefit funds are the most at risk. According to research from Bank of America at the end of April, the average funded ratio of the top 100 US corporate defined benefit pension plans sat at 77%, and this figure was calculated before the post-Brexit yield slump. The funding ratio of 77% indicates that the $3trn pension universe surveyed is running a $500bn funding gap.

Unsustainable deficit 

Here in the UK, it’s estimated that 11m people are reliant on defined benefit pension schemes and after recent market movements it’s estimated that UK pension deficits hit a record £935bn this week.

There’s no doubt that this is a colossal sum and meeting these liabilities is going to cause a serious headache for the worst-offending companies.

For example, BT’s pension deficit has increased by more than 50% in 18 months (to the end of May). Analysts at investment bank Macquarie believe the deficit now stands at £10.6bn. To put this figure into some perspective in the year to 31 March 2016, BT reported a pre-tax profit of £2.6bn. Macquarie believes that considering the present deficit, BT will have to pay £1bn per annum through to 2030 to fill the pension black hole.

The big question now being asked is, will companies ever be out to meet these pension liabilities?

Unfortunately, there’s now a very real chance that many businesses won’t be able to meet these obligations as deficits at some companies eclipse profits. Meanwhile, the UK’s Pension Protection Fund, a government-sponsored lifeboat for collapsed pension schemes, only has a funding surplus of £4.8bn, that’s just 0.51% of the total value of pension deficits as reported last week.

The figures really speak for themselves. The UK’s pension deficit is only getting worse, and there seems to be no way out.

Protect yourself 

The best way to protect yourself from the upcoming pensions bombshell could be to look after your own pension by investing in shares. And the best way to invest for the highest return is to look to high-quality blue chips with international operations, sustainable dividends and records of achieving the best returns for investors. Companies such as Unilever, AstraZeneca and GlaxoSmithKline all meet these criteria, but there are many more. 

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

These British dividend stocks have been flying in 2026. I think there could be more to come!

If you think dividend stocks are boring, think again. Paul Summers looks at three FTSE 100 giants whose share prices…

Read more »

Investing Articles

Down 50%! 1 beaten-down FTSE 100 growth share to consider buying instead of Rolls-Royce

Harvey Jones highlights a growth share that has had a very bumpy five years but may finally be pointing in…

Read more »

Young Woman Drives Car With Dog in Back Seat
Investing Articles

How much is needed in an ISA to earn a £750 monthly passive income?

Christopher Ruane explains the timeline, approach and some risks of using the annual ISA contribution limit to build passive income…

Read more »

Investing Articles

Down 50% with a P/E of just 6.6! Should I buy even more of this stupidly cheap value stock?

Harvey Jones reckons this value stock has more recovery potential than any other blue-chip. So why isn't it flying with…

Read more »

Young female hand showing five fingers.
Investing Articles

Diageo: 5 reasons why a FTSE 100 turnaround is still possible

Diageo gave investors an all-too-familiar fright this week. So, why does this writer think things could improve in future for…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

With a P/E of 13 and 4.3% dividend yield, should I consider buying Greggs shares now?

Paul Summers takes a fresh look at the battered FTSE 250 baker. Is now the time to finally load up…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

After making a fortune on Tesla, Scottish Mortgage manager Baillie Gifford is piling into this ‘mini-SpaceX’ growth stock

Ben McPoland was intrigued to learn this well-known institutional investor has been loading up on a little-known growth stock recently.

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

Here’s how I’m aiming for a million in my Stocks and Shares ISA

The best way to aim for a million in a Stocks and Shares ISA is by slow and steady progress…

Read more »